Page last updated: 2024-08-24

bms 186318 and carbamates

bms 186318 has been researched along with carbamates in 4 studies

*Carbamates: Derivatives of carbamic acid, H2NC(=O)OH. Included under this heading are N-substituted and O-substituted carbamic acids. In general carbamate esters are referred to as urethanes, and polymers that include repeating units of carbamate are referred to as POLYURETHANES. Note however that polyurethanes are derived from the polymerization of ISOCYANATES and the singular term URETHANE refers to the ethyl ester of carbamic acid. [MeSH]

*Carbamates: Derivatives of carbamic acid, H2NC(=O)OH. Included under this heading are N-substituted and O-substituted carbamic acids. In general carbamate esters are referred to as urethanes, and polymers that include repeating units of carbamate are referred to as POLYURETHANES. Note however that polyurethanes are derived from the polymerization of ISOCYANATES and the singular term URETHANE refers to the ethyl ester of carbamic acid. [MeSH]

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmad, S; Alam, M; Barrish, JC; Bechtold, CM; Chen, P; Gordon, E; Greytok, J; Patick, AK; Tino, JA; Zahler, R1
Barrish, JC; Bechtold, CM; Chen, PT; Colonno, RJ; Greytok, J; Hermsmeier, MA; Lin, PF; Patick, AK; Rose, R; Zahler, R1
Alam, M; Bechtold, CM; Colonno, RJ; Gong, YF; Greytok, JA; Lin, PF; Robinson, BS; Rose, RE; Terry, BJ1
Hawthorne, D; Jemal, M1

Other Studies

4 other study(ies) available for bms 186318 and carbamates

ArticleYear
Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and protease.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:2

    Topics: Antiviral Agents; Carbamates; Cell Line; Ethanolamines; Gene Products, gag; HIV Protease Inhibitors; HIV-1; Humans; Protein Precursors; Simian Immunodeficiency Virus

1995
Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor.
    Journal of virology, 1995, Volume: 69, Issue:4

    Topics: Amino Acid Sequence; Base Sequence; Carbamates; Cell Line; DNA Primers; Drug Resistance, Microbial; Ethanolamines; Genetic Variation; HeLa Cells; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Molecular Sequence Data; Sequence Homology, Amino Acid; Serial Passage

1995
Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Feb-20, Volume: 93, Issue:4

    Topics: Amino Acid Sequence; Carbamates; Clone Cells; DNA Mutational Analysis; DNA, Recombinant; DNA, Viral; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Ethanolamines; HeLa Cells; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoquinolines; Methylurea Compounds; Molecular Sequence Data; Point Mutation; Proviruses; Pyridines; Quinolines; Reassortant Viruses; Recombinant Fusion Proteins; Saquinavir; T-Lymphocytes; Urea; Valine

1996
Determination of BMS-186318 in dog, rat and monkey plasma by liquid chromatography-ionspray mass spectrometry.
    Journal of pharmaceutical and biomedical analysis, 1995, Volume: 14, Issue:1-2

    Topics: Animals; Calibration; Carbamates; Chromatography, High Pressure Liquid; Dogs; Ethanolamines; Haplorhini; HIV Protease Inhibitors; Indicators and Reagents; Mass Spectrometry; Quality Control; Rats; Species Specificity

1995